Vestor Capital LLC reduced its position in CME Group Inc. (NASDAQ:CME – Free Report) by 15.4% in the 1st quarter, Holdings Channel reports. The firm owned 59,212 shares of the financial services provider’s stock after selling 10,755 shares during the quarter. CME Group accounts for about 1.3% of Vestor Capital LLC’s portfolio, making the stock its 24th largest position. Vestor Capital LLC’s holdings in CME Group were worth $17,488,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Norges Bank purchased a new stake in shares of CME Group during the fourth quarter worth $1,523,241,000. Victory Capital Management Inc. lifted its stake in shares of CME Group by 746.4% in the fourth quarter. Victory Capital Management Inc. now owns 2,049,649 shares of the financial services provider’s stock worth $559,720,000 after buying an additional 1,807,491 shares in the last quarter. Bank of America Corp DE boosted its position in CME Group by 39.1% during the first quarter. Bank of America Corp DE now owns 4,019,944 shares of the financial services provider’s stock worth $1,187,290,000 after acquiring an additional 1,130,587 shares during the last quarter. Life Cycle Investment Partners Ltd acquired a new position in CME Group during the fourth quarter worth about $217,656,000. Finally, Viking Global Investors LP purchased a new stake in CME Group during the 2nd quarter valued at about $164,648,000. Hedge funds and other institutional investors own 87.75% of the company’s stock.
CME Group Price Performance
CME stock opened at $267.36 on Friday. CME Group Inc. has a 52-week low of $218.31 and a 52-week high of $329.16. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The stock has a market cap of $96.88 billion, a price-to-earnings ratio of 22.68, a price-to-earnings-growth ratio of 3.09 and a beta of 0.25. The business has a fifty day moving average of $251.35 and a two-hundred day moving average of $281.15.
CME Group Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Thursday, June 25th. Shareholders of record on Tuesday, June 9th were given a dividend of $1.30 per share. The ex-dividend date was Tuesday, June 9th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.9%. CME Group’s dividend payout ratio (DPR) is currently 44.11%.
Analyst Upgrades and Downgrades
A number of research firms have weighed in on CME. Barclays decreased their target price on shares of CME Group from $316.00 to $270.00 and set an “equal weight” rating on the stock in a research note on Thursday, July 9th. Wall Street Zen cut CME Group from a “hold” rating to a “sell” rating in a report on Sunday, July 12th. Piper Sandler reduced their price objective on CME Group from $329.00 to $295.00 and set an “overweight” rating on the stock in a research report on Wednesday, July 15th. JPMorgan Chase & Co. boosted their price objective on CME Group from $249.00 to $250.00 and gave the stock an “underweight” rating in a research note on Thursday, July 23rd. Finally, Bank of America upped their target price on CME Group from $226.00 to $230.00 and gave the company an “underperform” rating in a report on Thursday, July 23rd. Eleven equities research analysts have rated the stock with a Buy rating, four have assigned a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat.com, CME Group presently has an average rating of “Hold” and a consensus price target of $291.81.
View Our Latest Research Report on CME Group
Insider Activity
In related news, CEO Terrence A. Duffy sold 35,000 shares of the stock in a transaction that occurred on Friday, May 15th. The shares were sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the completion of the transaction, the chief executive officer owned 55,630 shares of the company’s stock, valued at approximately $16,606,111.30. This trade represents a 38.62% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director William R. Shepard bought 325 shares of the company’s stock in a transaction that occurred on Thursday, June 25th. The stock was bought at an average price of $230.57 per share, with a total value of $74,935.25. Following the acquisition, the director directly owned 260,442 shares in the company, valued at $60,050,111.94. The trade was a 0.12% increase in their position. The SEC filing for this purchase provides additional information. Insiders own 0.30% of the company’s stock.
Key CME Group News
Here are the key news stories impacting CME Group this week:
- Positive Sentiment: Expanded retail access to futures: TradeStation is expanding its futures offering to include CME Group’s spot-quoted futures, potentially increasing participation, liquidity and transaction volume across CME’s markets. TradeStation Expands Futures Offering with CME Group Spot-Quoted Futures
- Positive Sentiment: Entry into sports-related derivatives: CME Group plans to launch cash-settled futures tied to sports performance indexes through a partnership with FutureSports. The initiative targets the roughly $650 billion global sports industry and could create a new source of trading and clearing revenue if it receives regulatory approval and attracts hedging demand. CME Group Targets $650 Billion Sports Industry With First Sports Index Futures
- Positive Sentiment: Recent earnings beat expectations: CME’s latest quarterly results exceeded consensus estimates, with earnings per share of $2.99 versus $2.91 expected and revenue of $1.71 billion versus $1.68 billion expected. Revenue increased year over year, reinforcing the company’s strong operating performance and high margins.
- Neutral Sentiment: Federal Reserve holds rates steady: The Fed kept its benchmark rate at 3.50%–3.75%, in line with expectations. The decision does not materially change CME’s outlook, though future rate uncertainty can support activity in interest-rate and other derivatives markets. Fed Holds Rates Between 3.50% and 3.75%
- Negative Sentiment: Minor earnings-estimate reduction: Erste Group Bank lowered its FY2027 EPS forecast to $12.91 from $12.94 and maintained a “Hold” rating. The small revision signals limited near-term upside from that analyst, though the estimate remains above the broader current-year consensus of $12.27.
About CME Group
CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
See Also
- Five stocks we like better than CME Group
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
